Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale (Q41629044)

5 October 2017

1 reference

title

Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale (English)

1 reference

5 October 2017

1 reference

Livingston PO

1

1 reference

5 October 2017

Zhang S

series ordinal

2

1 reference

5 October 2017

Lloyd KO

series ordinal

3

1 reference

5 October 2017

1 October 1997

1 reference

Cancer Immunology, Immunotherapy

5 October 2017

1 reference

5 October 2017

45

1 reference

5 October 2017

1

1 reference

5 October 2017

1-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s002620050394

5 October 2017

0 references

cites work

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Individually distinct transplantation antigens of chemically induced mouse tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Induction of autoreactive B cells allows priming of autoreactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Ganglioside conjugate vaccines. Immunotherapy against tumors of neuroectodermal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

T cell recognition of carbohydrates on type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Biological roles of oligosaccharides: all of the theories are correct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Structures and functions of the sugar chains of glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Carbohydrate-Specific Receptors of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

The selectins and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Coexpression of GD3 ganglioside with CD45RO in resting and activated human T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

T lymphocyte heterogeneity in the rat. III. Autoreactive T cells are activated by B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Immunologic rejection of human cancer transplanted with a renal allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Transplanted carcinoma in an immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Immunogenicity of melanoma-associated gangliosides in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Human monoclonal antibody to ganglioside GM2 for melanoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Gangliosides of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

T and Tn, general carcinoma autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002620050394

21 January 2018

Identifiers

DOI

10.1007/S002620050394

1 reference

Dimensions Publication ID

5 October 2017

0 references

1 reference